                Figure 4.  Evolution of the disease activity score with time.A selection of 34 age- and gender-matched patients (16 asymptomatic, 18 symptomatic, median age: 72 years) were reevaluated after 2 years. The disease activity score, assessed on visit 1 and visit 2 was compared using the Wilcoxon test.

